ReviewFrontiers in endocrinology2025
The mechanism of oxidative stress in asthenozoospermia and antioxidant strategies: a review.
Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Oxidative Stress and Inflammatory Biomarkers in Male Infertility: A Narrative Review of Diagnostic Value and Clinical Integration.Diagnostics (Basel, Switzerland) · 2026Review
- The Gut-Extracellular Vesicle-Mitochondria Axis in Reproductive Aging: Antioxidant and Anti-Senescence Mechanisms.Antioxidants (Basel, Switzerland) · 2026Review
- A modular, mechanism-informed biomarker panel for asthenozoospermia based on integrative sperm proteomics.Frontiers in endocrinology · 2026Article
- Research progress on active ingredients of traditional Chinese medicine in the treatment of asthenozoospermia.Frontiers in reproductive health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asthenozoospermia, a leading cause of male infertility, is closely associated with oxidative stress (OS), which reflects an imbalance between reactive oxygen species (ROS) production and antioxidant capacity. ROS originate from both endogenous sources (e.g., inflammation and infection) and exogenous exposures (e.g., lifestyle and environmental pollutants). At physiological levels, ROS participate in key processes such as sperm proliferation, maturation, capacitation, acrosome reaction, and fertilization. However, excessive ROS become detrimental, damaging sperm membrane lipids, DNA integrity, and mitochondrial function, ultimately leading to reduced sperm motility and impaired fertility. A systematic understanding of the sources and mechanisms of ROS in asthenozoospermia is essential for developing targeted interventions. This review highlights the comprehensive integration of multiple ROS sources and their multi-level damaging effects, with a particular focus on mitochondrial dysfunction as a central mechanism in OS-induced sperm damage. Furthermore, we discuss the potential of antioxidant-based strategies and propose future directions for targeted therapies. This work aims to provide new insights into the treatment of asthenozoospermia and facilitate a shift from empirical management to mechanism-targeted therapies in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.